RiskScore was positively correlated with several immune checkpoint genes, including CD44, CD276, CD80, LGALS9, and CTLA4 (Fig. 6E), showing that HCC patients with higher RiskScore may be more possibly to experience immune escape. This evidence concerns the gene CD276 and hepatocellular carcinoma.